Show
Silverman WA†, Chalmers I (2002).
Casting and drawing lots: a time-honoured way of dealing with uncertainty and for ensuring fairness. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Armitage P† (2003).
Some recollections of the early years of the Medical Research Council (MRC) Statistical Research Unit. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
O'Rourke K (2006).
A historical perspective on meta-analysis: dealing quantitatively with varying study results. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Dickersin K, Chalmers I (2010).
Recognising, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the World Health Organisation. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Tröhler U (2010).
The introduction of numerical methods to assess the effects of medical interventions during the 18th century: a brief history. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Kaptchuk TJ (2011).
A brief history of the evolution of methods to control observer biases in tests of treatments. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Marušić A, Fatović-Ferenčić S (2012).
Adoption of the double dummy trial design to reduce observer bias in testing treatments. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Clarke M (2015).
History of evidence synthesis to assess treatment effects: personal reflections on something that is very much alive. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Altman DG†, Simera I (2015).
A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Gachelin G, Garner P, Ferroni E, Tröhler U, Chalmers I (2016).
Evaluating Cinchona bark and quinine for treating and preventing malaria. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Mirza RD, Punja S, Vohra S, Guyatt G (2017).
The history and development of N of 1 trials. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Wartolowska K, Beard DJ, Carr AJ (2017).
The use of placebos in controlled trials of surgical interventions: a brief history. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Chalmers I (2019).
Doug Altman’s prescience in recognizing the need to reduce biases before tackling imprecision in Systematic Reviews. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Johnson A† (2019).
Textbooks and other publications on controlled clinical trials, 1948 to 1983. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Matthews RAJ (2020).
The origins of the treatment of uncertainty in clinical medicine. Part 2: the emergence of probability theory and its limitations. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Tröhler U (2020)
Probabilistic thinking and the evaluation of therapies, 1700-1900. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Trahair B, Peters L (2020).
James Lind’s descendants. 2nd edition (supersedes Peters L 2006). JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Matthews RAJ (2020).
The origins of the treatment of uncertainty in clinical medicine. Part 1: Ancient roots, familiar disputes. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Brinkmann R, Podolsky SH (2021).
The ‘Personal Equation’ as observer bias, and proposed methods to contain it in Anglo-American medicine. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Clarke M (2021).
The true meaning of DICE: Don’t Ignore Chance Effects JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Lee A (2022).
The development of network meta-analysis. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Glasziou P, Matthews R, Boutron I, Chalmers I, Armitage P† (2023)
The differences and overlaps between ‘explanatory’ and ‘pragmatic’ controlled trials: a historical perspective. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Nothing found, please try resetting your search filters
